Active substances

Aminoglutethimide›

L02BG01 Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Aromatase inhibitors

Indicated for: Cushing syndrome; breast cancer

Aminophylline›

R03DA05 Respiratory system | Other systemic drugs for obstructive airway diseases | Xanthines

Indicated for: asthma; chronic obstructive pulmonary disease

Amiodarone›

C01BD01 Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class III

Indicated for: cardiac arrhythmias

Amisulpride›

N05AL05 Nervous system | Antipsychotics | Benzamides

Indicated for: schizophrenia; bipolar disorder

Amitriptyline›

N06AA09 Nervous system | Antidepressants | Non-selective monoamine reuptake inhibitors

Indicated for: depression; neuropathic pain

Amivantamab›

L01FX18 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates

Indicated for: non-small cell lung cancer

Amlodipine›

C08CA01 Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives

Indicated for: hypertension

Amlodipine + valsartan›

C09DB01 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers

Indicated for: hypertension

Amlodipine + valsartan + hydrochlorothiazide›

C09DX01 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs), other combinations

Indicated for: hypertension

Amobarbital›

N05CA02 Nervous system | Hypnotics and sedatives | Barbiturates, plain

Indicated for: insomnia

Amorolfine›

D01AE16 Dermatologicals | Antifungals for topical use | Other antifungals for topical use

Indicated for: onychomycosis

Amoxicillin›

J01CA04 Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Penicillins with extended spectrum

Indicated for: bacterial infections

Amoxicillin + clavulanic acid›

J01CR02 Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors

Indicated for: bacterial infections

Amoxicillin + metronidazole›

A02BDN1 Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Combinations for eradication of helicobacter pylori

Indicated for: bacterial infections

Amphotericin B›

J02AA01 Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Antibiotics

Indicated for: fungal infections

Ampicillin›

J01CA01 Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Penicillins with extended spectrum

Indicated for: bacterial infections

Ampicillin + cloxacillin›

J01CR50 Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors

Indicated for: bacterial infections

Ampicillin + sulbactam›

J01CR01 Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors

Indicated for: bacterial infections

Amprenavir›

J05AE05 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Indicated for: HIV-1 infection

Amylmetacresol + dichlorobenzyl alcohol›

R02AA03 Respiratory system | Throat preparations | Throat preparations | Antiseptics

Indicated for: sore throat; oropharyngeal inflammation

Amylmetacresol + dichlorobenzyl alcohol + levomenthol›

R02AA03 Respiratory system | Throat preparations | Throat preparations | Antiseptics

Indicated for: sore throat; nasopharyngeal congestion

Anagrelide›

L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents

Indicated for: essential thrombocythemia

Anakinra›

L04AC03 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors

Indicated for: autoimmune inflammatory diseases

Anastrozole›

L02BG03 Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Aromatase inhibitors

Indicated for: breast cancer

Andexanet alfa›

V03AB38 Various | All other therapeutic products | All other therapeutic products | Antidotes

Indicated for: reversal of factor Xa inhibitor anticoagulation

Angiotensin II›

C01CX09 Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Other cardiac stimulants

Indicated for: shock; acute hypotension

Anhydrous betaine›

A16AA06 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Amino acids and derivatives

Indicated for: homocystinuria

Anidulafungin›

J02AX06 Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Other antimycotics for systemic use

Indicated for: invasive candidiasis; fungal infections

Anifrolumab›

L04AG11 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Monoclonal antibodies

Indicated for: systemic lupus erythematosus

Antazoline + sodium cromoglicate›

S01GA52 Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants

Indicated for: allergic conjunctivitis